Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction
Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer
It aims to make the state-of-the-art modern and safe surgical care, typically available in super-speciality hospitals of big cities, accessible, affordable, standardized and integrated
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development
Eubio Isoquercetin derived from Sophora Japonica is expected to deliver more Quercetin to the body via small doses of Isoquercetin.
New biotechnology product aims to be world's fastest automatic sanitary solution
The funds will be used to expand digital product offerings, grow their online customer base, and launch their flagship clinic in Bengaluru
New role strengthens Quantori’s global leadership position in data science & digital IT
UCB plans to submit regulatory applications in Q3 2022
Subscribe To Our Newsletter & Stay Updated
